Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
This study was designed to provide 12 weeks efficacy and safety data of the 150 μg once-daily
(od) dose of indacaterol in chronic obstructive pulmonary disease (COPD).